Paul Frederick Bente, Iv

Title: Paul Frederick Bente, Iv: Innovator in Insulin Therapy

Introduction

Paul Frederick Bente, Iv is a notable inventor based in Westford, MA (US). He has made significant contributions to the field of insulin therapy, particularly through his innovative patent that addresses meal bolus subcategories in model-based insulin therapy. His work is crucial for improving the management of diabetes.

Latest Patents

Bente holds a patent titled "Meal bolus subcategories in model based insulin therapy." This patent discloses methods for receiving information related to meal ingestion, including the size, timing, and composition of the meal. It also involves identifying blood glucose measurement values within a specific time range after meal ingestion. The patent outlines how to modify a meal model to determine the appropriate dose of insulin to be delivered, enhancing the effectiveness of insulin therapy.

Career Highlights

Bente is associated with Insulet Corporation, a company known for its innovative approaches to diabetes management. His work at Insulet has allowed him to focus on developing advanced solutions that improve patient outcomes. With a patent count of 1 patent, he continues to contribute to the field of medical technology.

Collaborations

Bente has collaborated with notable colleagues such as Thomas Metzmaker and Nicholas Conte. Their combined expertise in the field has fostered advancements in insulin delivery systems and diabetes care.

Conclusion

Paul Frederick Bente, Iv is a key figure in the development of insulin therapy innovations. His patent work and collaborations reflect his commitment to improving diabetes management through technology.